ID   KAPCA_MOUSE             Reviewed;         351 AA.
AC   P05132; Q9JID0;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-JUL-2015, entry version 192.
DE   RecName: Full=cAMP-dependent protein kinase catalytic subunit alpha;
DE            Short=PKA C-alpha;
DE            EC=2.7.11.11;
GN   Name=Prkaca; Synonyms=Pkaca;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=2833513;
RA   Chrivia J.C., Uhler M.D., McKnight G.S.;
RT   "Characterization of genomic clones coding for the C alpha and C beta
RT   subunits of mouse cAMP-dependent protein kinase.";
RL   J. Biol. Chem. 263:5739-5744(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3456589; DOI=10.1073/pnas.83.5.1300;
RA   Uhler M.D., Carmichael D.F., Lee D.C., Chrivia J.C., Krebs E.G.,
RA   McKnight G.S.;
RT   "Isolation of cDNA clones coding for the catalytic subunit of mouse
RT   cAMP-dependent protein kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:1300-1304(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=FVB/N-3; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-153 (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=10982398; DOI=10.1091/mbc.11.9.3031;
RA   San Agustin J.T., Wilkerson C.G., Witman G.B.;
RT   "The unique catalytic subunit of sperm cAMP-dependent protein kinase
RT   is the product of an alternative C-alpha mRNA expressed specifically
RT   in spermatogenic cells.";
RL   Mol. Biol. Cell 11:3031-3044(2000).
RN   [5]
RP   PHOSPHORYLATION AT SER-11; SER-140; THR-198 AND SER-339.
RX   PubMed=8395513;
RA   Yonemoto W., Garrod S.M., Bell S.M., Taylor S.S.;
RT   "Identification of phosphorylation sites in the recombinant catalytic
RT   subunit of cAMP-dependent protein kinase.";
RL   J. Biol. Chem. 268:18626-18632(1993).
RN   [6]
RP   PHOSPHORYLATION AT THR-198 BY PDPK1.
RX   PubMed=9707564; DOI=10.1073/pnas.95.17.9849;
RA   Cheng X., Ma Y., Moore M., Hemmings B.A., Taylor S.S.;
RT   "Phosphorylation and activation of cAMP-dependent protein kinase by
RT   phosphoinositide-dependent protein kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:9849-9854(1998).
RN   [7]
RP   MYRISTOYLATION AT GLY-2, PHOSPHORYLATION AT SER-11, AND DEAMIDATION AT
RP   ASN-3.
RX   PubMed=11141074; DOI=10.1021/bi0021277;
RA   Tholey A., Pipkorn R., Bossemeyer D., Kinzel V., Reed J.;
RT   "Influence of myristoylation, phosphorylation, and deamidation on the
RT   structural behavior of the N-terminus of the catalytic subunit of
RT   cAMP-dependent protein kinase.";
RL   Biochemistry 40:225-231(2001).
RN   [8]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=11875122; DOI=10.1210/me.16.3.630;
RA   Skaalhegg B.S., Huang Y., Su T., Idzerda R.L., McKnight G.S.,
RA   Burton K.A.;
RT   "Mutation of the Calpha subunit of PKA leads to growth retardation and
RT   sperm dysfunction.";
RL   Mol. Endocrinol. 16:630-639(2002).
RN   [9]
RP   FUNCTION IN SPERMATOZOA CAPACITATION (ISOFORM 2), AND TISSUE
RP   SPECIFICITY (ISOFORM 2).
RX   PubMed=15340140; DOI=10.1073/pnas.0405580101;
RA   Nolan M.A., Babcock D.F., Wennemuth G., Brown W., Burton K.A.,
RA   McKnight G.S.;
RT   "Sperm-specific protein kinase A catalytic subunit Calpha2
RT   orchestrates cAMP signaling for male fertility.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:13483-13488(2004).
RN   [10]
RP   SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=18367160; DOI=10.1016/j.ydbio.2008.01.045;
RA   Webb R.J., Tinworth L., Thomas G.M., Zaccolo M., Carroll J.;
RT   "Developmentally acquired PKA localisation in mouse oocytes and
RT   embryos.";
RL   Dev. Biol. 317:36-45(2008).
RN   [11]
RP   FUNCTION IN MEIOSIS RESUMPTION, FUNCTION AS CDC25B KINASE, AND
RP   INTERACTION WITH CDC25B.
RX   PubMed=19223768;
RA   Pirino G., Wescott M.P., Donovan P.J.;
RT   "Protein kinase A regulates resumption of meiosis by phosphorylation
RT   of Cdc25B in mammalian oocytes.";
RL   Cell Cycle 8:665-670(2009).
RN   [12]
RP   FUNCTION IN SPERMATOZOA CAPACITATION, FUNCTION AS ABL1 KINASE, AND
RP   INTERACTION WITH ABL1.
RX   PubMed=19560455; DOI=10.1016/j.ydbio.2009.06.022;
RA   Baker M.A., Hetherington L., Curry B., Aitken R.J.;
RT   "Phosphorylation and consequent stimulation of the tyrosine kinase c-
RT   Abl by PKA in mouse spermatozoa; its implications during
RT   capacitation.";
RL   Dev. Biol. 333:57-66(2009).
RN   [13]
RP   PHOSPHORYLATION AT TYR-331.
RX   PubMed=21866565; DOI=10.1002/jcb.23325;
RA   Caldwell G.B., Howe A.K., Nickl C.K., Dostmann W.R., Ballif B.A.,
RA   Deming P.B.;
RT   "Direct modulation of the protein kinase A catalytic subunit alpha by
RT   growth factor receptor tyrosine kinases.";
RL   J. Cell. Biochem. 113:39-48(2012).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=1862342; DOI=10.1126/science.1862342;
RA   Knighton D.R., Zheng J., ten Eyck L.F., Ashford V.A., Xuong N.-H.,
RA   Taylor S.S., Sowadski J.M.;
RT   "Crystal structure of the catalytic subunit of cyclic adenosine
RT   monophosphate-dependent protein kinase.";
RL   Science 253:407-414(1991).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF COMPLEX WITH INHIBITOR.
RX   PubMed=8443157; DOI=10.1021/bi00060a005;
RA   Zheng J., Knighton D.R., ten Eyck L.F., Karlsson R., Xuong N.-H.,
RA   Taylor S.S., Sowadski J.M.;
RT   "Crystal structure of the catalytic subunit of cAMP-dependent protein
RT   kinase complexed with MgATP and peptide inhibitor.";
RL   Biochemistry 32:2154-2161(1993).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF COMPLEX WITH INHIBITOR.
RX   PubMed=9109651; DOI=10.1021/bi961947+;
RA   Narayana N., Cox S., Shaltiel S., Taylor S.S., Xuong N.;
RT   "Crystal structure of a polyhistidine-tagged recombinant catalytic
RT   subunit of cAMP-dependent protein kinase complexed with the peptide
RT   inhibitor PKI(5-24) and adenosine.";
RL   Biochemistry 36:4438-4448(1997).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS).
RX   PubMed=9261084; DOI=10.1016/S0969-2126(97)00246-3;
RA   Narayana N., Cox S., Nguyen-Huu X., ten Eyck L.F., Taylor S.S.;
RT   "A binary complex of the catalytic subunit of cAMP-dependent protein
RT   kinase and adenosine further defines conformational flexibility.";
RL   Structure 5:921-935(1997).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) IN COMPLEX WITH ATP ANALOG.
RX   PubMed=17889648; DOI=10.1016/j.cell.2007.07.018;
RA   Kim C., Cheng C.Y., Saldanha S.A., Taylor S.S.;
RT   "PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent
RT   activation.";
RL   Cell 130:1032-1043(2007).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS).
RX   PubMed=17932298; DOI=10.1126/science.1146447;
RA   Wu J., Brown S.H., von Daake S., Taylor S.S.;
RT   "PKA type IIalpha holoenzyme reveals a combinatorial strategy for
RT   isoform diversity.";
RL   Science 318:274-279(2007).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) IN COMPLEX WITH ADP, SUBUNIT,
RP   AND MUTAGENESIS OF LYS-286 AND PHE-328.
RX   PubMed=19122195; DOI=10.1074/jbc.M805862200;
RA   Yang J., Kennedy E.J., Wu J., Deal M.S., Pennypacker J., Ghosh G.,
RA   Taylor S.S.;
RT   "Contribution of non-catalytic core residues to activity and
RT   regulation in protein kinase A.";
RL   J. Biol. Chem. 284:6241-6248(2009).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.62 ANGSTROMS) IN COMPLEX WITH ATP ANALOGS.
RX   PubMed=19748511; DOI=10.1016/j.jmb.2009.09.014;
RA   Brown S.H.J., Wu J., Kim C., Alberto K., Taylor S.S.;
RT   "Novel isoform-specific interfaces revealed by PKA RIIbeta holoenzyme
RT   structures.";
RL   J. Mol. Biol. 393:1070-1082(2009).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEX WITH ATP ANALOG AND
RP   SUBSTRATE PEPTIDE, AND ENZYME REGULATION.
RX   PubMed=20890288; DOI=10.1038/nchembio.452;
RA   Masterson L.R., Cheng C., Yu T., Tonelli M., Kornev A., Taylor S.S.,
RA   Veglia G.;
RT   "Dynamics connect substrate recognition to catalysis in protein kinase
RT   A.";
RL   Nat. Chem. Biol. 6:821-828(2010).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 2-351 IN COMPLEX WITH
RP   PRKAR2B, SUBUNIT, AND PHOSPHORYLATION AT SER-140 AND THR-198.
RX   PubMed=22323819; DOI=10.1126/science.1213979;
RA   Zhang P., Smith-Nguyen E.V., Keshwani M.M., Deal M.S., Kornev A.P.,
RA   Taylor S.S.;
RT   "Structure and allostery of the PKA RIIbeta tetrameric holoenzyme.";
RL   Science 335:712-716(2012).
CC   -!- FUNCTION: Phosphorylates a large number of substrates in the
CC       cytoplasm and the nucleus. Regulates the abundance of
CC       compartmentalized pools of its regulatory subunits through
CC       phosphorylation of PJA2 which binds and ubiquitinates these
CC       subunits, leading to their subsequent proteolysis. Phosphorylates
CC       CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA and VASP.
CC       RORA is activated by phosphorylation. Required for glucose-
CC       mediated adipogenic differentiation increase and osteogenic
CC       differentiation inhibition from osteoblasts. Involved in the
CC       regulation of platelets in response to thrombin and collagen;
CC       maintains circulating platelets in a resting state by
CC       phosphorylating proteins in numerous platelet inhibitory pathways
CC       when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-
CC       alpha (NFKBIA), but thrombin and collagen disrupt these complexes
CC       and free active PRKACA stimulates platelets and leads to platelet
CC       aggregation by phosphorylating VASP. Prevents the
CC       antiproliferative and anti-invasive effects of alpha-
CC       difluoromethylornithine in breast cancer cells when activated.
CC       RYR2 channel activity is potentiated by phosphorylation in
CC       presence of luminal Ca(2+), leading to reduced amplitude and
CC       increased frequency of store overload-induced Ca(2+) release
CC       (SOICR) characterized by an increased rate of Ca(2+) release and
CC       propagation velocity of spontaneous Ca(2+) waves, despite reduced
CC       wave amplitude and resting cytosolic Ca(2+). PSMC5/RPT6 activation
CC       by phosphorylation stimulates proteasome. Negatively regulates
CC       tight junctions (TJs) in ovarian cancer cells via CLDN3
CC       phosphorylation. NFKB1 phosphorylation promotes NF-kappa-B p50-p50
CC       DNA binding. Involved in embryonic development by down-regulating
CC       the Hedgehog (Hh) signaling pathway that determines embryo pattern
CC       formation and morphogenesis. Prevents meiosis resumption in
CC       prophase-arrested oocytes via CDC25B inactivation by
CC       phosphorylation. May also regulate rapid eye movement (REM) sleep
CC       in the pedunculopontine tegmental (PPT). Phosphorylates APOBEC3G
CC       and AICDA. Isoform 2 phosphorylates and activates ABL1 in sperm
CC       flagellum to promote spermatozoa capacitation (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Allosterically activated by various compounds,
CC       including ATP. Activated by cAMP; the nucleotide acts as a dynamic
CC       and allosteric activator by coupling the two lobes of apo PKA,
CC       enhancing the enzyme dynamics synchronously and priming it for
CC       catalysis. {ECO:0000269|PubMed:20890288}.
CC   -!- SUBUNIT: A number of inactive tetrameric holoenzymes are produced
CC       by the combination of homo- or heterodimers of the different
CC       regulatory subunits associated with two catalytic subunits.
CC       Protein kinase A holoenzyme is comprised of two catalytic (C) and
CC       two regulatory (R) subunits which keep the enzyme in an inhibited
CC       state before activation by cyclic-AMP. cAMP causes the
CC       dissociation of the inactive holoenzyme into a dimer of regulatory
CC       subunits bound to four cAMP and two free monomeric catalytic
CC       subunits. The cAMP-dependent protein kinase catalytic subunit
CC       binds PJA2. Both isoforms 1 and 2 forms activate cAMP-sensitive
CC       PKAI and PKAII holoenzymes by interacting with regulatory subunit
CC       (R) of PKA, PRKAR1A/PKR1 and PRKAR2A/PKR2, respectively. Interacts
CC       with NFKB1, NFKB2 and NFKBIA in platelets; these interactions are
CC       disrupted by thrombin and collagen. Binds to ABL1 in spermatozoa
CC       and with CDC25B in oocytes. Interacts with APOBEC3G and AICDA (By
CC       similarity). Interacts with RAB13; downstream effector of RAB13
CC       involved in tight junction assembly (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:22323819}.
CC   -!- INTERACTION:
CC       P31324:Prkar2b; NbExp=3; IntAct=EBI-400564, EBI-455340;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18367160}.
CC       Cell membrane {ECO:0000250}. Nucleus {ECO:0000250}. Mitochondrion
CC       {ECO:0000269|PubMed:18367160}. Note=Translocates into the nucleus
CC       (monomeric catalytic subunit) (By similarity). The inactive
CC       holoenzyme is found in the cytoplasm. Distributed throughout the
CC       cytoplasm in meiotically incompetent oocytes. Associated to
CC       mitochondrion as meiotic competence is acquired. Aggregates around
CC       the germinal vesicles (GV) at the immature GV stage oocytes.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell projection, cilium,
CC       flagellum {ECO:0000250}. Note=Expressed in the midpiece region of
CC       the sperm flagellum. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=C-alpha-1;
CC         IsoId=P05132-1; Sequence=Displayed;
CC       Name=2; Synonyms=C-alpha-2, C-alpha-S, C(s);
CC         IsoId=P05132-2; Sequence=VSP_004760;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is sperm specific.
CC   -!- DEVELOPMENTAL STAGE: Accumulates in oocytes before fertilization
CC       but fades out after fertilization. {ECO:0000269|PubMed:18367160}.
CC   -!- PTM: Autophosphorylated. Phosphorylation is enhanced by vitamin
CC       K(2) (By similarity). Phosphorylated on threonine and serine
CC       residues. Phosphorylation on Thr-198 is required for full
CC       activity. {ECO:0000250, ECO:0000269|PubMed:8395513,
CC       ECO:0000269|PubMed:9707564}.
CC   -!- PTM: Asn-3 is partially deaminated to Asp-3 giving rise to 2 major
CC       isoelectric variants, called CB and CA respectively.
CC   -!- PTM: When myristoylated, Ser-11 is autophosphorylated probably in
CC       conjunction with deamidation of Asn-3.
CC       {ECO:0000269|PubMed:11141074, ECO:0000269|PubMed:8395513}.
CC   -!- PTM: Phosphorylated at Tyr-331 by activated receptor tyrosine
CC       kinases EGFR and PDGFR; this increases catalytic efficienncy.
CC       {ECO:0000269|PubMed:21866565}.
CC   -!- DISRUPTION PHENOTYPE: Frequent early postnatal lethality.
CC       Survivals are runted accompanied with mature sperm exhibiting
CC       defective forward motility. {ECO:0000269|PubMed:11875122}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cAMP subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M19960; AAA39937.1; -; Genomic_DNA.
DR   EMBL; M18240; AAA39937.1; JOINED; Genomic_DNA.
DR   EMBL; M18241; AAA39937.1; JOINED; Genomic_DNA.
DR   EMBL; M19953; AAA39937.1; JOINED; Genomic_DNA.
DR   EMBL; M19954; AAA39937.1; JOINED; Genomic_DNA.
DR   EMBL; M19955; AAA39937.1; JOINED; Genomic_DNA.
DR   EMBL; M19956; AAA39937.1; JOINED; Genomic_DNA.
DR   EMBL; M19957; AAA39937.1; JOINED; Genomic_DNA.
DR   EMBL; M19958; AAA39937.1; JOINED; Genomic_DNA.
DR   EMBL; M19959; AAA39937.1; JOINED; Genomic_DNA.
DR   EMBL; M12303; AAA39936.1; -; mRNA.
DR   EMBL; BC003238; AAH03238.1; -; mRNA.
DR   EMBL; BC054834; AAH54834.1; -; mRNA.
DR   EMBL; AF239743; AAF76425.1; -; mRNA.
DR   CCDS; CCDS22463.1; -. [P05132-1]
DR   PIR; A28619; OKMSCA.
DR   RefSeq; NP_001264827.1; NM_001277898.1. [P05132-2]
DR   RefSeq; NP_032880.1; NM_008854.5. [P05132-1]
DR   UniGene; Mm.19111; -.
DR   PDB; 1APM; X-ray; 2.00 A; E=2-351.
DR   PDB; 1ATP; X-ray; 2.20 A; E=2-351.
DR   PDB; 1BKX; X-ray; 2.60 A; A=2-351.
DR   PDB; 1BX6; X-ray; 2.10 A; A=2-351.
DR   PDB; 1FMO; X-ray; 2.20 A; E=2-351.
DR   PDB; 1J3H; X-ray; 2.90 A; A/B=2-351.
DR   PDB; 1JBP; X-ray; 2.20 A; E=2-351.
DR   PDB; 1JLU; X-ray; 2.25 A; E=2-351.
DR   PDB; 1L3R; X-ray; 2.00 A; E=2-351.
DR   PDB; 1PVK; Model; -; B=16-351.
DR   PDB; 1RDQ; X-ray; 1.26 A; E=2-351.
DR   PDB; 1RE8; X-ray; 2.10 A; A=2-351.
DR   PDB; 1REJ; X-ray; 2.20 A; A=2-351.
DR   PDB; 1REK; X-ray; 2.30 A; A=2-351.
DR   PDB; 1SYK; X-ray; 2.80 A; A/B=2-351.
DR   PDB; 2CPK; X-ray; 2.70 A; E=2-351.
DR   PDB; 2ERZ; X-ray; 2.20 A; E=1-351.
DR   PDB; 2QCS; X-ray; 2.20 A; A=2-351.
DR   PDB; 2QUR; X-ray; 2.50 A; A=2-351.
DR   PDB; 2QVS; X-ray; 2.50 A; E=2-351.
DR   PDB; 3FHI; X-ray; 2.00 A; A=2-351.
DR   PDB; 3FJQ; X-ray; 1.60 A; E=2-351.
DR   PDB; 3IDB; X-ray; 1.62 A; A=2-351.
DR   PDB; 3IDC; X-ray; 2.70 A; A=2-351.
DR   PDB; 3J4Q; EM; 35.00 A; D/E=1-351.
DR   PDB; 3J4R; EM; 35.00 A; D/E=1-351.
DR   PDB; 3O7L; X-ray; 2.80 A; B/D=2-351.
DR   PDB; 3OW3; X-ray; 1.90 A; A=2-351.
DR   PDB; 3PVB; X-ray; 3.30 A; A=7-351.
DR   PDB; 3QAL; X-ray; 1.70 A; E=2-351.
DR   PDB; 3QAM; X-ray; 1.92 A; E=2-351.
DR   PDB; 3TNP; X-ray; 2.30 A; C/F=2-351.
DR   PDB; 3TNQ; X-ray; 3.10 A; B=2-351.
DR   PDB; 4DFX; X-ray; 1.35 A; E=2-351.
DR   PDB; 4DFY; X-ray; 3.00 A; A/E=1-351.
DR   PDB; 4DFZ; X-ray; 2.00 A; E=2-351.
DR   PDB; 4DG0; X-ray; 2.00 A; E=2-351.
DR   PDB; 4DG2; X-ray; 2.00 A; E=2-351.
DR   PDB; 4DG3; X-ray; 1.80 A; E=1-351.
DR   PDB; 4DH1; X-ray; 2.00 A; A=16-351.
DR   PDB; 4DH3; X-ray; 2.20 A; A=2-351.
DR   PDB; 4DH5; X-ray; 2.20 A; A=2-351.
DR   PDB; 4DH7; X-ray; 1.80 A; A=2-351.
DR   PDB; 4DH8; X-ray; 2.30 A; A=2-351.
DR   PDB; 4DIN; X-ray; 3.70 A; A=2-351.
DR   PDB; 4HPT; X-ray; 2.15 A; E=2-351.
DR   PDB; 4HPU; X-ray; 1.55 A; E=2-351.
DR   PDB; 4IAC; X-ray; 2.15 A; A=2-351.
DR   PDB; 4IAD; X-ray; 1.90 A; A=2-351.
DR   PDB; 4IAF; X-ray; 2.20 A; A=2-351.
DR   PDB; 4IAI; X-ray; 1.55 A; A=2-351.
DR   PDB; 4IAK; X-ray; 1.60 A; A=2-351.
DR   PDB; 4IAY; X-ray; 2.00 A; A=2-351.
DR   PDB; 4IAZ; X-ray; 1.85 A; A=2-351.
DR   PDB; 4IB0; X-ray; 1.87 A; A=2-351.
DR   PDB; 4IB1; X-ray; 1.63 A; A=2-351.
DR   PDB; 4IB3; X-ray; 2.20 A; A=2-351.
DR   PDB; 4NTS; X-ray; 2.90 A; A/B=2-351.
DR   PDB; 4NTT; X-ray; 3.50 A; A/B=2-351.
DR   PDB; 4O21; X-ray; 1.95 A; A=16-351.
DR   PDB; 4O22; X-ray; 1.70 A; A=16-351.
DR   PDB; 4WBB; X-ray; 2.80 A; B=2-351.
DR   PDB; 4XW4; X-ray; 1.82 A; A=15-351.
DR   PDB; 4XW5; X-ray; 1.95 A; A=15-351.
DR   PDB; 4XW6; X-ray; 1.90 A; A=15-351.
DR   PDBsum; 1APM; -.
DR   PDBsum; 1ATP; -.
DR   PDBsum; 1BKX; -.
DR   PDBsum; 1BX6; -.
DR   PDBsum; 1FMO; -.
DR   PDBsum; 1J3H; -.
DR   PDBsum; 1JBP; -.
DR   PDBsum; 1JLU; -.
DR   PDBsum; 1L3R; -.
DR   PDBsum; 1PVK; -.
DR   PDBsum; 1RDQ; -.
DR   PDBsum; 1RE8; -.
DR   PDBsum; 1REJ; -.
DR   PDBsum; 1REK; -.
DR   PDBsum; 1SYK; -.
DR   PDBsum; 2CPK; -.
DR   PDBsum; 2ERZ; -.
DR   PDBsum; 2QCS; -.
DR   PDBsum; 2QUR; -.
DR   PDBsum; 2QVS; -.
DR   PDBsum; 3FHI; -.
DR   PDBsum; 3FJQ; -.
DR   PDBsum; 3IDB; -.
DR   PDBsum; 3IDC; -.
DR   PDBsum; 3J4Q; -.
DR   PDBsum; 3J4R; -.
DR   PDBsum; 3O7L; -.
DR   PDBsum; 3OW3; -.
DR   PDBsum; 3PVB; -.
DR   PDBsum; 3QAL; -.
DR   PDBsum; 3QAM; -.
DR   PDBsum; 3TNP; -.
DR   PDBsum; 3TNQ; -.
DR   PDBsum; 4DFX; -.
DR   PDBsum; 4DFY; -.
DR   PDBsum; 4DFZ; -.
DR   PDBsum; 4DG0; -.
DR   PDBsum; 4DG2; -.
DR   PDBsum; 4DG3; -.
DR   PDBsum; 4DH1; -.
DR   PDBsum; 4DH3; -.
DR   PDBsum; 4DH5; -.
DR   PDBsum; 4DH7; -.
DR   PDBsum; 4DH8; -.
DR   PDBsum; 4DIN; -.
DR   PDBsum; 4HPT; -.
DR   PDBsum; 4HPU; -.
DR   PDBsum; 4IAC; -.
DR   PDBsum; 4IAD; -.
DR   PDBsum; 4IAF; -.
DR   PDBsum; 4IAI; -.
DR   PDBsum; 4IAK; -.
DR   PDBsum; 4IAY; -.
DR   PDBsum; 4IAZ; -.
DR   PDBsum; 4IB0; -.
DR   PDBsum; 4IB1; -.
DR   PDBsum; 4IB3; -.
DR   PDBsum; 4NTS; -.
DR   PDBsum; 4NTT; -.
DR   PDBsum; 4O21; -.
DR   PDBsum; 4O22; -.
DR   PDBsum; 4WBB; -.
DR   PDBsum; 4XW4; -.
DR   PDBsum; 4XW5; -.
DR   PDBsum; 4XW6; -.
DR   ProteinModelPortal; P05132; -.
DR   SMR; P05132; 2-351.
DR   BioGrid; 202192; 19.
DR   DIP; DIP-6086N; -.
DR   IntAct; P05132; 13.
DR   MINT; MINT-4051347; -.
DR   STRING; 10090.ENSMUSP00000005606; -.
DR   BindingDB; P05132; -.
DR   PhosphoSite; P05132; -.
DR   MaxQB; P05132; -.
DR   PaxDb; P05132; -.
DR   PRIDE; P05132; -.
DR   Ensembl; ENSMUST00000005606; ENSMUSP00000005606; ENSMUSG00000005469. [P05132-1]
DR   GeneID; 18747; -.
DR   KEGG; mmu:18747; -.
DR   UCSC; uc009mll.3; mouse. [P05132-1]
DR   UCSC; uc009mlm.2; mouse. [P05132-2]
DR   CTD; 5566; -.
DR   MGI; MGI:97592; Prkaca.
DR   eggNOG; COG0515; -.
DR   GeneTree; ENSGT00790000122941; -.
DR   HOGENOM; HOG000233033; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P05132; -.
DR   KO; K04345; -.
DR   OMA; NAATANK; -.
DR   OrthoDB; EOG7VX8WD; -.
DR   PhylomeDB; P05132; -.
DR   TreeFam; TF313399; -.
DR   BRENDA; 2.7.11.11; 3474.
DR   Reactome; REACT_272448; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; REACT_276302; Loss of Nlp from mitotic centrosomes.
DR   Reactome; REACT_278699; Hedgehog 'off' state.
DR   Reactome; REACT_280010; Factors involved in megakaryocyte development and platelet production.
DR   Reactome; REACT_286537; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; REACT_286837; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; REACT_287123; PKA-mediated phosphorylation of key metabolic factors.
DR   Reactome; REACT_294984; Interleukin-3, 5 and GM-CSF signaling.
DR   Reactome; REACT_295338; PKA activation in glucagon signalling.
DR   Reactome; REACT_297430; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; REACT_306614; Regulation of insulin secretion.
DR   Reactome; REACT_307305; Rap1 signalling.
DR   Reactome; REACT_308431; Gluconeogenesis.
DR   Reactome; REACT_310780; Degradation of GLI2 by the proteasome.
DR   Reactome; REACT_310977; PKA activation.
DR   Reactome; REACT_315885; VEGFA-VEGFR2 Pathway.
DR   Reactome; REACT_316390; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   Reactome; REACT_325290; DARPP-32 events.
DR   Reactome; REACT_328862; Anchoring of the basal body to the plasma membrane.
DR   Reactome; REACT_336227; PKA-mediated phosphorylation of CREB.
DR   Reactome; REACT_345278; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; REACT_353777; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; REACT_359387; Degradation of GLI1 by the proteasome.
DR   Reactome; REACT_360524; CD209 (DC-SIGN) signaling.
DR   ChiTaRS; Prkaca; mouse.
DR   EvolutionaryTrace; P05132; -.
DR   NextBio; 294909; -.
DR   PRO; PR:P05132; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   Bgee; P05132; -.
DR   CleanEx; MM_PRKACA; -.
DR   Genevisible; P05132; MM.
DR   GO; GO:0031588; C:AMP-activated protein kinase complex; ISO:MGI.
DR   GO; GO:0005952; C:cAMP-dependent protein kinase complex; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; ISO:MGI.
DR   GO; GO:0097546; C:ciliary base; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:MGI.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0097225; C:sperm midpiece; ISO:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004691; F:cAMP-dependent protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; ISO:MGI.
DR   GO; GO:0004672; F:protein kinase activity; IDA:MGI.
DR   GO; GO:0019901; F:protein kinase binding; ISO:MGI.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:MGI.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; ISO:MGI.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:MGI.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; ISO:MGI.
DR   GO; GO:0071374; P:cellular response to parathyroid hormone stimulus; IMP:MGI.
DR   GO; GO:0001707; P:mesoderm formation; IGI:MGI.
DR   GO; GO:0051447; P:negative regulation of meiotic cell cycle; IEA:Ensembl.
DR   GO; GO:1901621; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IGI:MGI.
DR   GO; GO:0001843; P:neural tube closure; IGI:MGI.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:MGI.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:MGI.
DR   GO; GO:0071158; P:positive regulation of cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; IMP:MGI.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:MGI.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:MGI.
DR   GO; GO:2000810; P:regulation of bicellular tight junction assembly; ISO:MGI.
DR   GO; GO:0043457; P:regulation of cellular respiration; IEA:Ensembl.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; ISO:MGI.
DR   GO; GO:0061136; P:regulation of proteasomal protein catabolic process; ISO:MGI.
DR   GO; GO:0070613; P:regulation of protein processing; IGI:MGI.
DR   GO; GO:0050804; P:regulation of synaptic transmission; IMP:MGI.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0048240; P:sperm capacitation; IDA:UniProtKB.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR002290; Ser/Thr_dual-sp_kinase.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; cAMP; Cell membrane;
KW   Cell projection; Cilium; Complete proteome; Cytoplasm; Flagellum;
KW   Kinase; Lipoprotein; Membrane; Mitochondrion; Myristate;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P00517}.
FT   CHAIN         2    351       cAMP-dependent protein kinase catalytic
FT                                subunit alpha.
FT                                /FTId=PRO_0000086053.
FT   DOMAIN       44    298       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      299    351       AGC-kinase C-terminal.
FT   NP_BIND      50     58       ATP.
FT   NP_BIND     122    128       ATP.
FT   NP_BIND     169    172       ATP.
FT   ACT_SITE    167    167       Proton acceptor.
FT   BINDING      73     73       ATP.
FT   MOD_RES       3      3       Deamidated asparagine; partial.
FT                                {ECO:0000269|PubMed:11141074}.
FT   MOD_RES      11     11       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11141074,
FT                                ECO:0000269|PubMed:8395513}.
FT   MOD_RES      49     49       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P17612}.
FT   MOD_RES     140    140       Phosphoserine.
FT                                {ECO:0000269|PubMed:22323819,
FT                                ECO:0000305|PubMed:8395513}.
FT   MOD_RES     196    196       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P17612}.
FT   MOD_RES     198    198       Phosphothreonine; by PDPK1.
FT                                {ECO:0000269|PubMed:22323819,
FT                                ECO:0000269|PubMed:8395513,
FT                                ECO:0000269|PubMed:9707564}.
FT   MOD_RES     202    202       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P17612}.
FT   MOD_RES     331    331       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:21866565}.
FT   MOD_RES     339    339       Phosphoserine.
FT                                {ECO:0000305|PubMed:8395513}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:11141074}.
FT   VAR_SEQ       1     15       MGNAAAAKKGSEQES -> MASSSND (in isoform
FT                                2). {ECO:0000303|PubMed:10982398}.
FT                                /FTId=VSP_004760.
FT   MUTAGEN     198    198       T->D: No phosphorylation by PDPK1.
FT   MUTAGEN     286    286       K->P: Impaired inhibition by the R-
FT                                subunit. {ECO:0000269|PubMed:19122195}.
FT   MUTAGEN     328    328       F->A: Reduced catalytic activity and
FT                                impaired inhibition by the R-subunit.
FT                                {ECO:0000269|PubMed:19122195}.
FT   CONFLICT     33     33       T -> D (in Ref. 2; AAA39936).
FT                                {ECO:0000305}.
FT   CONFLICT    287    287       N -> D (in Ref. 2; AAA39936).
FT                                {ECO:0000305}.
FT   HELIX         3      7       {ECO:0000244|PDB:4DFX}.
FT   TURN          9     12       {ECO:0000244|PDB:4DFX}.
FT   HELIX        16     32       {ECO:0000244|PDB:1RDQ}.
FT   HELIX        41     43       {ECO:0000244|PDB:1RDQ}.
FT   STRAND       44     52       {ECO:0000244|PDB:1RDQ}.
FT   STRAND       57     63       {ECO:0000244|PDB:1RDQ}.
FT   TURN         64     66       {ECO:0000244|PDB:1RDQ}.
FT   STRAND       69     76       {ECO:0000244|PDB:1RDQ}.
FT   HELIX        77     82       {ECO:0000244|PDB:1RDQ}.
FT   HELIX        86     96       {ECO:0000244|PDB:1RDQ}.
FT   STRAND      107    112       {ECO:0000244|PDB:1RDQ}.
FT   STRAND      114    122       {ECO:0000244|PDB:1RDQ}.
FT   HELIX       129    136       {ECO:0000244|PDB:1RDQ}.
FT   HELIX       141    160       {ECO:0000244|PDB:1RDQ}.
FT   STRAND      162    164       {ECO:0000244|PDB:1BKX}.
FT   HELIX       170    172       {ECO:0000244|PDB:1RDQ}.
FT   STRAND      173    175       {ECO:0000244|PDB:1RDQ}.
FT   STRAND      181    183       {ECO:0000244|PDB:1RDQ}.
FT   HELIX       186    188       {ECO:0000244|PDB:1RE8}.
FT   HELIX       203    205       {ECO:0000244|PDB:1RDQ}.
FT   HELIX       208    211       {ECO:0000244|PDB:1RDQ}.
FT   HELIX       219    234       {ECO:0000244|PDB:1RDQ}.
FT   HELIX       244    253       {ECO:0000244|PDB:1RDQ}.
FT   HELIX       264    273       {ECO:0000244|PDB:1RDQ}.
FT   TURN        278    280       {ECO:0000244|PDB:1RDQ}.
FT   TURN        282    284       {ECO:0000244|PDB:4XW6}.
FT   TURN        286    289       {ECO:0000244|PDB:1RDQ}.
FT   HELIX       290    293       {ECO:0000244|PDB:1RDQ}.
FT   HELIX       296    298       {ECO:0000244|PDB:1RDQ}.
FT   HELIX       303    307       {ECO:0000244|PDB:1RDQ}.
FT   STRAND      321    326       {ECO:0000244|PDB:1REK}.
FT   TURN        345    350       {ECO:0000244|PDB:1RDQ}.
SQ   SEQUENCE   351 AA;  40571 MW;  02F85D66EB21A1FA CRC64;
     MGNAAAAKKG SEQESVKEFL AKAKEDFLKK WETPSQNTAQ LDQFDRIKTL GTGSFGRVML
     VKHKESGNHY AMKILDKQKV VKLKQIEHTL NEKRILQAVN FPFLVKLEFS FKDNSNLYMV
     MEYVAGGEMF SHLRRIGRFS EPHARFYAAQ IVLTFEYLHS LDLIYRDLKP ENLLIDQQGY
     IQVTDFGFAK RVKGRTWTLC GTPEYLAPEI ILSKGYNKAV DWWALGVLIY EMAAGYPPFF
     ADQPIQIYEK IVSGKVRFPS HFSSDLKDLL RNLLQVDLTK RFGNLKNGVN DIKNHKWFAT
     TDWIAIYQRK VEAPFIPKFK GPGDTSNFDD YEEEEIRVSI NEKCGKEFTE F
//
